Jane Street’s Caris Life Sciences CAI Stock Holding History

Jane Street’s Portfolio CAI Stock Details CAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-170,997	Closed	-$3.74M	–	13495
2025 Q4	$4.61M	Buy	170,997 +156,402	+1,072%	+$4.4M	﹤0.01%	3359
2025 Q3	$441K	Buy	+14,595	New	+$465K	﹤0.01%	8123

Other funds holding CAI

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JHWEPV

J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

SSP

Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return

PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Jane Street's CAI Position: Q1 2026 in Review

Jane Street sold out of Caris Life Sciences (CAI) in Q1 2026, closing a stake of 170,997 shares — an estimated $3.74M sold.

Jane Street first reported a position in CAI in Q3 2025 and held it in 2 quarters. The position peaked at $4.61M in Q4 2025. 202 funds tracked by Wall St. Rank hold CAI as of Q1 2026.

Jane Street reported no remaining Caris Life Sciences position as of Q1 2026 after selling out during the quarter.
Jane Street sold 170,997 Caris Life Sciences shares in Q1 2026, an estimated $3.74M.
Jane Street first reported a position in Caris Life Sciences in Q3 2025 and held it in 2 quarters.
Jane Street's Caris Life Sciences position peaked at $4.61M in Q4 2025.
202 funds tracked by Wall St. Rank held Caris Life Sciences as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.